Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblastsManagement to discuss the ongoing Phase 1/2 diabetic foot ulcer trial, upcoming clinical catalysts, broader pipeline opportunities, and an…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.